Major biopharma partnering, investor, scientific, CRO/outsourcing, regulatory, manufacturing/CMC, digital health/AI and market access/HEOR meetings in the United States, Europe, Japan and Asia-Pacific over the next six months, updated as dates are announced. Investor conferences are generally invitation‑only.